Systems Pharmacology to Predict Drug Toxicity: Integration Across Levels of Biological OrganizationBAI, Jane P. F; ABERNETHY, Darrell R.Annual review of pharmacology and toxicology (Print). 2013, Vol 53, pp 451-473, issn 0362-1642, 23 p.Article

Effect of Obesity on the Pharmacokinetics of Drugs in HumansHANLEY, Michael J; ABERNETHY, Darrell R; GREENBLATT, David J et al.Clinical pharmacokinetics. 2010, Vol 49, Num 2, pp 71-87, issn 0312-5963, 17 p.Article

Metrologic approaches to setting acceptance criteria : Unacceptable and unusual characteristicsHAUCK, Walter W; ABERNETHY, Darrell R; WILLIAMS, Roger L et al.Journal of pharmaceutical and biomedical analysis. 2008, Vol 48, Num 3, pp 1042-1045, issn 0731-7085, 4 p.Article

A Pilot Randomized Clinical Trial Utilizing the Drug Burden Index to Reduce Exposure to Anticholinergic and Sedative Medications in Older PeopleGNJIDIC, Danijela; LE COUTEUR, David G; ABERNETHY, Darrell R et al.The Annals of pharmacotherapy. 2010, Vol 44, Num 11, pp 1725-1732, issn 1060-0280, 8 p.Article

Mapping the dose-effect relationship of orbofiban from sparse data with an artificial neural networkMAGER, Donald E; SHIREY, Jason D; COX, Dermot et al.Journal of pharmaceutical sciences. 2005, Vol 94, Num 11, pp 2475-2486, issn 0022-3549, 12 p.Article

Metal Impurities in Food and DrugsABERNETHY, Darrell R; DESTEFANO, Anthony J; CECIL, Todd L et al.Pharmaceutical research. 2010, Vol 27, Num 5, pp 750-755, issn 0724-8741, 6 p.Article

Stereoselective halofantrine disposition and effect: concentration-related QTc prolongationABERNETHY, Darrell R; WESCHE, David L; BARBEY, Jean T et al.British journal of clinical pharmacology. 2001, Vol 51, Num 3, pp 231-237, issn 0306-5251Article

Loratadine and terfenadine interaction with nefazodone : Both antihistamines are associated with QTc prolongationABERNETHY, Darrell R; BARBEY, Jean T; FRANC, John et al.Clinical pharmacology and therapeutics. 2001, Vol 69, Num 3, pp 96-103, issn 0009-9236Article

Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiolTANUS-SANTOS, Jose E; DESAI, Mehul; DEAK, Leslie R et al.Pharmacogenetics (London). 2002, Vol 12, Num 5, pp 407-413, issn 0960-314XArticle

Pharmacodynamic profile of short-term readministration of abciximab in healthy subjectsFREEDMAN, Jane; MASCELLI, Mary A; PEZZULLO, John C et al.The American heart journal. 2002, Vol 143, Num 1, pp 87-94, issn 0002-8703Article

a drug burden index to define the functional burden of medications in older people. Commentary : A step forwardAGOSTINI, Joseph V; HILMER, Sarah N; SHORR, Ronald I et al.Archives of internal medicine (1960). 2007, Vol 167, Num 8, issn 0003-9926, 753-754,781-787 [9 p.]Article

Pharmacodynamics of abciximab during angioplasty: Comparison to healthy subjectsABERNETHY, Darrell R; PEZZULLO, John; MASCELLI, Mary A et al.Clinical pharmacology and therapeutics. 2002, Vol 71, Num 3, pp 186-195, issn 0009-9236Article

Where Are We Now and Where Should We Be in the Future?CHO, Seongeun; JOHNNY LAU, S. W; TANDON, Veneeta et al.Archives of internal medicine (1960). 2011, Vol 171, Num 10, pp 937-940, issn 0003-9926, 4 p.Article

Drug Burden Index and physical function in older Australian menGNJIDIC, Danijela; CUMMING, Robert G; LE COUTEUR, David G et al.British journal of clinical pharmacology. 2009, Vol 68, Num 1, pp 97-105, issn 0306-5251, 9 p.Article

Abciximab pharmacodynamic model with neural networks used to integrate sources of patient variabilityURQUIDI-MACDONALD, Mirna; MAGER, Donald E; MASCELLI, Mary A et al.Clinical pharmacology and therapeutics. 2004, Vol 75, Num 1, pp 60-69, issn 0009-9236, 10 p.Article

Effect of angiotensin-converting enzyme insertion/deletion polymorphism DD genotype on high-frequency heart rate variability in African AmericansTHAYER, Julian F; MERRITT, Marcellus M; SOLLERS, John J et al.The American journal of cardiology. 2003, Vol 92, Num 12, pp 1487-1490, issn 0002-9149, 4 p.Article